A meta analysis of nucleos(t)ide analogues in patients with decompensated cirrhosis due to hepatitis B
Background and Aim:The effect of nucleos(t)ide analogues(NUCs) therapy in patients with decompensated cirrhosis remains unclear.We evaluate the NUCs” effect in these patients.Methods:An electronic search of the Pubmed,Web of Science,Embase,the Cochrane Central of Register of Controlled Trials (CCTR) and China Biology Medicine disc (CBM) from 1998-01-01 to 2011-09-05 was conducted.A meta-analysis was performed.Relative risks (RRs) of mortality rate,Child-Pugh-Turcotte (CPT)score and HBeAg seroconversion of the decompensated patients were studied.
hepatitis B, chronic liver cirrhosis, decompensated nucleos(t)ide analogues
Yingnan Huang Shengdi Wu Xizhong Shen
Department of Gastroenterology,Zhongshan Hospital of Fudan University,Shanghai,200032,PR China Department of Gastroenterology,Zhongshan Hospital of Fudan University,180 Fenglin Road,Shanghai 2000
国内会议
昆明
英文
119-120
2012-08-01(万方平台首次上网日期,不代表论文的发表时间)